U.S. Insurance Stock News

NasdaqGM:CRVS
NasdaqGM:CRVSBiotechs

Corvus Pharmaceuticals (CRVS) Is Up 7.3% After Promising Soquelitinib Data And Extended Cash Runway

In recent months, Corvus Pharmaceuticals reported encouraging Phase 1 results for its oral ITK inhibitor soquelitinib in atopic dermatitis, showing early efficacy signals alongside a clean safety profile and extending its cash runway into the second quarter of 2028. These developments, coupled with upbeat coverage from investment commentators highlighting soquelitinib’s potential to compete in immunology and attract larger partners, have drawn fresh attention to Corvus’s pipeline and funding...
NYSE:OMC
NYSE:OMCMedia

McCann Study On Upward Class Puts Omnicom Valuation In Focus

McCann, an Omnicom Group (NYSE:OMC) subsidiary, released a new global study on brand relevance and growth strategies. The research introduces the "Upward Class," a large and influential consumer group shaping how brands grow worldwide. The findings highlight changing expectations for how brands connect with this audience and maintain relevance. For Omnicom Group, a global advertising and marketing services company, this kind of research sits close to the core of its business. As clients...
NasdaqGM:HPK
NasdaqGM:HPKOil and Gas

Do Rising Middle East Supply Risks Redefine HighPeak Energy’s Role as a Swing Producer (HPK)?

Earlier this week, U.S. self-defense strikes on Iran heightened Middle East tensions, increasing concerns about potential disruptions to Iranian oil supply and shifting attention to alternative producers. This backdrop has put U.S. shale operators such as HighPeak Energy in sharper focus as potential contributors to any future global supply gaps, without necessarily altering the company’s longer-term fundamentals. Next, we’ll examine how heightened Middle East supply risk, and HighPeak’s...
NYSE:ONTO
NYSE:ONTOSemiconductor

If Global Tensions Reshape Energy Flows These Stocks Could Shine

Energy stocks are again in the spotlight as investors watch headlines about a possible U.S. Iran deal, G7 talks on wars and trade, and fresh debates on AI and global security. These stories are not just politics; they can influence oil supply routes, risk premiums, and sentiment toward large producers and refiners. For investors, that mix can create pockets of opportunity and pockets of risk. This article highlights 3 large energy stocks from our screener that look particularly exposed to...
NasdaqGS:GLPI
NasdaqGS:GLPISpecialized REITs

Will Earnings Beat And Dividend Hike Change Gaming and Leisure Properties' (GLPI) Income-Focused Narrative?

Earlier this week, Gaming and Leisure Properties reported first-quarter 2026 results that surpassed analyst expectations and raised its quarterly cash dividend to US$0.82 per share, underscoring the company’s current payout level to shareholders. On the same day, director E. Scott Urdang sold 3,000 shares as part of a year-long pattern of insider sales, while external analysts highlighted the REIT’s casino-focused portfolio and recurring rental income as key underpinnings of its cash flow...
NYSE:DEI
NYSE:DEIOffice REITs

Douglas Emmett (DEI) Stock Valuation After Recent Rebound And Modest Undervaluation Estimate

Douglas Emmett (DEI) has drawn investor attention after recent trading, with the stock last closing at US$12.28. You may be considering how this real estate investment trust’s fundamentals compare with its recent performance. See our latest analysis for Douglas Emmett. Recent trading has come after a period where the stock’s 90 day share price return of 27.78% contrasts with a 1 year total shareholder return that is down 12.45%. This suggests improving short term momentum after a weaker...
NasdaqGM:RLAY
NasdaqGM:RLAYBiotechs

Relay Therapeutics (RLAY) Stock Valuation After Analyst Upgrades On Early Zovegalisib Data

Recent analyst upgrades for Relay Therapeutics (RLAY) focus on early clinical data for its drug candidate zovegalisib. Initial results in PIK3CA-driven vascular anomalies, particularly in heavily treated patients, have drawn increased attention to the stock. See our latest analysis for Relay Therapeutics. The recent enthusiasm around zovegalisib comes on top of strong price momentum, with a 1-month share price return of 21.39%, a 3-month share price return of 46.20% and a year-to-date share...
NYSE:SPIR
NYSE:SPIRProfessional Services

Why Spire Global (SPIR) Is Up 6.2% After New Missile Early-Warning Satellite Partnership Announcement

Earlier this month, Diehl Defence announced it had signed a Memorandum of Understanding with Spire Global at the ILA Berlin Airshow 2026 to explore collaboration on satellite-based intelligence and early warning against ballistic and hypersonic missiles, drawing on Spire’s RF detection and analytics capabilities. This collaboration framework, paired with Spire’s new Munich facility capable of producing up to 100 satellites per year, highlights how the company is positioning itself as a...
NYSE:TROX
NYSE:TROXChemicals

Tronox Holdings (TROX) Is Up 9.3% After Beating Sustainability Targets And Closing Fuzhou Plant

Tronox Holdings has released its 2025 sustainability report, confirming it exceeded its environmental and safety targets and permanently closed its Fuzhou TiO₂ plant in China to better align operations with market conditions. The report links these environmental gains and footprint changes with progress in Tronox’s rare earths program, underscoring how sustainability efforts are being tied directly to future product and market opportunities. Next, we’ll examine how Tronox’s progress in rare...
NYSE:EDU
NYSE:EDUConsumer Services

How Investors Are Reacting To New Oriental (EDU) After Goldman Sachs Highlights Its US$5.4 Billion Net Cash

Earlier this month, Goldman Sachs upgraded New Oriental Education & Technology Group from Neutral to Buy, highlighting the company’s approximately US$5.40 billion net cash position and expectations for margin expansion in test preparation and livestreaming businesses. This reassessment by a major global bank underscores how New Oriental’s substantial cash reserves and improving profitability profile may be reshaping perceptions of its financial resilience. Next, we’ll examine how Goldman...
NYSE:YSS
NYSE:YSSAerospace & Defense

York Space Systems (YSS) Stock After June 12 Drop Assessing Valuation Versus Growth And Profit Concerns

York Space Systems (YSS) saw its stock drop more than 16% on June 12, 2026, after investors reacted to the planned SpaceX IPO and ongoing concerns around York’s profitability and sector volatility. See our latest analysis for York Space Systems. That sharp 1 day share price return of down 17.9% sits against a 30 day share price return of 15.3% and a 90 day share price return of 39.7%. This suggests recent momentum had been building before the latest pullback as investors weighed York’s...
NasdaqGS:HTO
NasdaqGS:HTOWater Utilities

How Executive Exit and Dividend Hike Will Impact H2O America (HTO) Investors

H2O America recently announced that executive Kristen Johnson will depart the company without cause, effective 3 July 2026, with severance provided under her employment agreement. Alongside this leadership change, H2O America has extended its 58-year dividend growth streak with a 4.8% quarterly increase and reaffirmed its 2026 earnings guidance. Next, we’ll examine how Johnson’s departure and the continued dividend growth track record may influence H2O America’s broader investment...
NasdaqGS:PONY
NasdaqGS:PONYSoftware

Is Pony AI (PONY) Using Luxembourg’s Robotaxi Pilot to Quietly Refine Its Europe Entry Strategy?

Bolt, Pony.ai, and Stellantis recently launched an autonomous mobility pilot in Luxembourg to test Pony.ai’s seventh-generation robotaxi on Stellantis’ L4-Ready midsize vans using Bolt’s ride-hailing platform. The project highlights Luxembourg’s supportive regulatory framework as a proving ground for validating Pony.ai’s autonomous driving technology and readiness for future European deployment. Next, we will examine how this European pilot, especially testing seventh-generation autonomous...
NYSE:GWW
NYSE:GWWTrade Distributors

W.W. Grainger (GWW) Stock After Strong 2024 Rally Is The Upside Now Limited

Investors may be considering whether W.W. Grainger at around US$1,315 per share still offers value, or if most of the opportunity is already priced in. The stock has posted returns of 1.2% over the last week, 3.4% over the last month, 31.1% year to date and 24.7% over the past year, which can change how investors think about both its potential and its risks. Recent coverage has focused on W.W. Grainger's role in industrial distribution and how it is positioning its operations and customer...
NasdaqGS:AROW
NasdaqGS:AROWBanks

One High Yield Dividend Growth Stock Three Quiet Compounders

With war in Iran disrupting oil supplies, energy prices jumping and inflation back at a three year high, the mood in markets has shifted fast. Higher U.S. Treasury yields and talk of fresh Federal Reserve rate hikes are putting pressure on richly priced growth stories, while investors pay closer attention to cash flow and balance sheet strength. Dividend growth stocks with solid financial footing can look appealing in this kind of backdrop, but not all are affected in the same way. This...
NYSE:KW
NYSE:KWReal Estate

Kennedy-Wilson (KW) Stock Looks 21.4% Overvalued After Strong Recent Shareholder Returns

Kennedy-Wilson Holdings (KW) has attracted fresh attention after recent trading, with the stock last closing at $10.93. For investors, that price stands in the context of mixed recent returns and sizeable exposure to global real estate. See our latest analysis for Kennedy-Wilson Holdings. Recent trading has been relatively muted, with a 1 day share price return of 0.09% and a 30 day share price return of 0.91%. However, a 13.38% year to date share price return sits alongside a 1 year total...